We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
The doctors’ body claims misuse of its identity in the drug’s promotion while the pharma firm asserts that it has email expressing support from the former.